Inventor
VIMOLRATANA MARC
US11 patents
⚠️ This page may combine multiple inventors who share the name “VIMOLRATANA MARC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
9 patentsUS9562061B2Feb 7, 2017
Compounds that inhibit MCL-1 protein
AMGEN INC39 citations96
US8030354B2Oct 4, 2011
Substituted biphenyl GPR40 modulators
AMGEN INC11 citations83
US10494381B2Dec 3, 2019
Compounds that inhibit Mcl-1 protein
AMGEN INC3 citations82
US10100063B2Oct 16, 2018
Compounds that inhibit Mcl-1 protein
AMGEN INC8 citations82
US11306107B2Apr 19, 2022
Compounds that inhibit MCL-1 protein
AMGEN INC2 citations71
US7572934B2Aug 11, 2009
Substituted biphenyl GPR40 modulators
AMGEN INC5 citations61
US10836779B2Nov 17, 2020
Compounds that inhibit MCL-1 protein
AMGEN INC0 citations51
US8003648B2Aug 23, 2011
Heterocyclic GPR40 modulators
AMGEN INC1 citations50
US7714008B2May 11, 2010
Heterocyclic GPR40 modulators
AMGEN INC0 citations50